Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance

HIGHLIGHTS

• who: Alexander J. Ryu from the (UNIVERSITY) have published the research: Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance, in the Journal: (JOURNAL) of December/31,/2021
• what: The authors propose this methodology as a low-cost precursor prior to examining drug candidates of interest in synthetic clinical trials or prospective trials.
• how: The associated hazard ratios for MGUS progression of each model feature are shown in Table 3.
• future: Drug repurposing studies may be conducted prospectively or using various forms of retrospective real-world . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.